As much as China wants to promote its nationally produced Covid-19 vaccines, it has to face reality.
Last month, Beijing issued a new policy that makes it easier for foreigners to apply for a visa in China if they have received a Chinese vaccine, which raises concerns among experts, who warn that there is a risk of setting a dangerous precedent that may leave the world separate in vaccine. Sitges.
There was also a practical problem: in many countries, including the United States, it is impossible to get a Chinese vaccine because regulators have not approved its use.
With about half of adults in the United States receiving at least one Covid-19 shot, many travelers eligible to enter China, whether Chinese or foreign nationals who obtain a visa, were unsure whether the vaccine would be considered they received. enough to travel to China.
The Chinese embassy in Washington finally provided some clarity in a recent statement, which explained what travelers in China who have received one of the U.S.-approved vaccines (Pfizer-BioNTech, Moderna and Johnson) should get. & Johnson) to be approved. enter the country.
With China largely back in business and low infection rates, it is likely that many will try this process soon, especially as the number of vaccinated continues to rise in the United States.
China considers Pfizer data: Last month, China launched its own version of a vaccine passport, the International Travel Health Certificate (ITHC), to allow vaccinated people to travel more freely. The country is also moving toward the approval of more vaccines, including foreign-made ones, that would make it easier for Chinese living abroad and foreigners hoping to travel to China to enroll in the ITC.
According to the Wall Street Journal, Chinese officials have been examining data from clinical trials for the Pfizer-BioNTech vaccine, which could be approved for home use before July.
Read the full story:
